AVNT vs UTHR · P/E 32, rev $1.76B vs P/E 20, rev $1.56B
Avient Corp (AVNT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Avient Corp (AVNT) is a specialty chemicals company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AVNT revenue for 2026-06-30 was $1.76B. Net income was $120.5M. AVNT currently screens at market cap $3.13B and trailing P/E 31.7.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
AVNT currently screens at market cap $3.13B and trailing P/E 31.7. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the AVNT and UTHR stock pages for the full models.
Not investment advice.